Heteroaryl derivative or pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition for preventing or treating diseases associated with PI3 kinases, containing same as active ingredient

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 10526337
APP PUB NO 20180105527A1
SERIAL NO

15567692

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a heteroaryl derivative represented by Formula 1

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGYDAEJEON 305-606

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cho, Heeyeong Daejeon, KR 10 7
Choi, Jung Hwan Gyeongsangnam-do, KR 81 334
Kim, Seong Hwan Daejeon, KR 51 45
Lee, Ge Hyeong Daejeon, KR 6 3
Lim, Hee-Jong Daejeon, KR 4 3
Park, Woo Kyu Chungcheongbuk-do, KR 7 37

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 7, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 7, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00